Stay updated on DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.

Latest updates to the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page
- CheckyesterdayChange DetectedThe site-wide banner announcing NIH terminology changes and linking to transition updates and FAQs was removed.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange Detected- The page now renders a 403 Forbidden error, replacing the previous study record content and navigation. This indicates access to the study details is blocked, preventing viewing the record for NCT02618915.SummaryDifference18%

Stay in the know with updates to DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.